FdaApplication
ANDA 209991
Identifiers
- fda_app_no: ANDA209991
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2023-09-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN; CLAVULANATE POTASSIUM | 875MG;EQ 125MG BASE | TABLET;ORAL |
1 product